R.E.D. Laboratories is a biotechnology company developing tests and therapies for chronic immune diseases. We actively pursue basic research programs to unravel the mechanisms leading to chronic disease development, and provide clinicians and researchers with unique and innovative tools to assess immune dysfunctions.
Please visit regularly our NEWS web page to stay informed about new avalable tests.
Our request forms (see below) have been updated on January 1st 2014. Several prices have been revised (decreased). Please download them from our website.
Please visit our Sample Preparation web page for detailed instruction about sampling (type of tubes to be used, shipping, etc)
IL-17 ELISA TEST
IL-17 ELISA test on human serum samples is now available.Interleukin-17 (IL-17) is a proinflammatory cytokine playing critical roles in both acute and chronic inflammatory responses. IL-17 play important roles in the clearance of extracellular bacterial and fungal infections. However, strong evidence also implicates IL-17 in several autoimmune disorders including multiple sclerosis, psoriasis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, and asthma.
Contact us for more information.
Mycoplasma fermentans PCR Analysis (MycoFERM PCR test)
A separate PCR assay for specific determination of Mycoplasma fermentans is now available and we are accepting different types of samples (blood, saliva, biopsies, etc).
Contact us for more information. See our updated request forms.
Metagenomics Stool Analysis (MSA test)
A new, state of the art procedure for stool microbial population analysis is now available at RED Laboratories. Our metagenomics stool analysis is based on bacterial 16S PCR amplification followed by high-throughput sequencing. It provides a complete overview of bacterial populations present in a stool sample, including aerobes, anaerobes, and bacterial species which cannot be analyzed by traditional culture techniques.
See Intestinal Dysfunction Assays page for more information.
Nagalase Activity Testing Analysis (NAGA test)Nagalase (alpha-N-acetylgalactosaminidase) activity testing on both serum and plasma is now available at RED Laboratories. As of January 1st 2014, the results for Nagalase testing done at RED Laboratories will be reported as a group containing the values for (i) apparent nagalase activity, (ii) Gc-globulin concentration, (iii) corrected Nagalase activity (i.e. effective nagalase activity) in function of the major natural substrate competitor Gc-globulin and (iv) an alternative immunomodulator enzyme for which we have choose Dipeptidyl-peptidase or CD26 present on T and B lymphocytes and macrophages as well as in numerous other cell populations in the body.
Please see the Nagalase page for more information.
See Nagalase Testing Request form for full information on sample preparation and shipping.
Important note regarding testing
Only health care practioners (physicians) have the capacity to decide whether or not a test is necessary. Depending on the medical history of the patients, they will decide which analysis should be performed and the conditions of sample collection. Result interpretation can only be made by a physician. We will not accept samples for analyses which have not been requested by a physician. Results will be sent only to the requesting physician. We will not give testing advice, or test result comments, directly to the patients.
VISIT US AT:
1. ILADS Conference (Augsburg April 25-26 2014) booth n°10
2. AutismOne Conference (Chicago May 21-25 2014)